口腔状細胞がんの病理を誘発する低酸素誘導因子の交差点:低酸素誘導因子とがん関連フィブロブラストの役割の免疫ヒストケミカル分析
Indu M1, Beena Vt2, Moinak Banerjee3
1Department of Oral Pathology, Govt Dental College Thrissur, Kerala, India.
Asian Pacific journal of cancer prevention : APJCP
|August 24, 2025
まとめ
低酸素誘導因子 (HIFs) は,口腔状細胞癌 (OSCC) で上昇し,がんに関連した線維細胞 (CAFs) と相関しています. これは,口腔がんの発症におけるCAF誘導に低酸素が影響を及ぼすことを示唆している.
科学分野:
- 腫瘍学
- 分子生物学
- 癌 研究
背景:
- 低酸素で特徴づけられる腫瘍低酸素は,低酸素誘導因子 (HIF) と関連している.
- 口腔状細胞癌 (OSCC) に関するHIFの役割は依然として議論されている.
- 腫瘍の微小環境内の癌に関連した線維芽細胞 (CAFs) に対する低酸素の影響については,さらなる解明が必要である.
研究 の 目的:
- HIF-1αとHIF-2αの発現をOSCCと正常な口腔組織で比較する.
- HIF-1α/HIF-2α発現とOSCCの臨床病理学的特徴の関連性を調査する.
- OSCCにおけるHIFとCAFの関係を決定する.
主な方法:
- HIF- 1α,HIF- 2αおよびα- 滑らかな筋肉アクチン (α- SMA) の発現を評価するために免疫ヒストロケミストリーが使用されました.
- 50個のOSCCと50個の正常な口腔粘膜 (NOM) のサンプルを分析した.
- 統計的分析にはANOVA,チ-スクエア,マン-ウィットニーUテストが含まれていた.
主要な成果:
- HIF- 1α,HIF- 2α,α- SMAの発現は,OSCCでは,NOMよりも有意に高かった (P < 0. 001).
- HIF- 1αとHIF- 2αの発現は,CAFのマーカーであるα- SMAと正の相関を示した.
- HIF発現と腫瘍組織学的分類との間に有意な関連性が見つかりませんでした.
結論:
- OSCCにおけるHIF発現の増加は,がんの病原性におけるその役割を支持する.
- HIFとα-SMAの相関は,口腔がんにおけるCAF誘導にヒポキシが寄与することを示唆する.
さらに関連する動画
関連する概念動画
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Hypoxia
1.2K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.2K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


